Si-Bone Inc (SIBN)

Currency in USD
13.83
-0.24(-1.71%)
Closed·
13.85+0.02(+0.14%)
·
SIBN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.6914.11
52 wk Range
12.5021.89
Key Statistics
Prev. Close
14.07
Open
13.92
Day's Range
13.69-14.11
52 wk Range
12.5-21.89
Volume
532.01K
Average Volume (3m)
543.3K
1-Year Change
-13.8854%
Book Value / Share
4.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SIBN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
25.67
Upside
+85.59%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Si-Bone Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Si-Bone Company Profile

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Si-Bone Inc SWOT Analysis


Surgical Innovation
SI-BONE's iFuse Implant System drives 22.6% YoY growth, establishing the company as a pioneer in minimally invasive sacroiliac joint surgery
Financial Health
Strong Q1 2025 performance with $47.3M in sales, 25% YoY increase. Healthy 79.25% gross margin and solid cash position, despite current overvaluation
Growth Trajectory
Analysts project 15-20%+ annual revenue growth. New product launches and FDA Breakthrough Device Designations poised to expand addressable market
Market Dynamics
Average analyst price target of $28.50. NTAP reimbursement of $3,960 for iFuse TORQ TNT expected in Q4 2025, potentially catalyzing adoption
Read full SWOT analysis

Si-Bone Inc Earnings Call Summary for Q4/2025

  • Q4 revenue hit record $56.3M, up 15% YoY, beating estimates of $54.7M; EPS of -$0.04 surpassed forecast of -$0.12 by 66.67%.
  • Company achieved first-ever positive cash flow and adjusted EBITDA of $5.1M, marking 176.2% improvement YoY with 79% gross margin.
  • Stock rose 0.97% to $15.48 post-earnings, reflecting positive market response to profitability progress and strong operational performance.
  • Management projects FY2026 revenue of $229.96M, focusing on ASC market expansion and product portfolio growth via R&D investments.
  • Key risks include ongoing net losses, high operating expenses, and macroeconomic pressures from inflation and supply chain disruptions.
Last Updated: 23/02/2026, 22:38
Read Full Transcript

Compare SIBN to Peers and Sector

Metrics to compare
SIBN
Peers
Sector
Relationship
P/E Ratio
−32.3x−4.1x−0.5x
PEG Ratio
−0.790.160.00
Price/Book
3.4x3.1x2.6x
Price / LTM Sales
3.0x1.9x3.2x
Upside (Analyst Target)
80.8%37.9%51.4%
Fair Value Upside
Unlock8.6%8.5%Unlock

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 25.67
(+85.59% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Truist Securities
Buy24.00+73.54%23.00Maintain24/02/2026
TD Cowen
Buy22.00+59.07%21.00Maintain24/02/2026
TD Cowen
Buy21.00+51.84%-New Coverage27/01/2026
Truist Securities
Buy23.00+66.31%21.00Maintain18/12/2025
Canaccord Genuity
Buy27.00+95.23%26.00Maintain17/12/2025

Earnings

Latest Release
Feb 23, 2026
EPS / Forecast
-0.04 / -0.12
Revenue / Forecast
56.30M / 54.70M
EPS Revisions
Last 90 days

People Also Watch

43.27
PLOW
-3.42%
17.83
CBLL
-0.34%
16.77
CMCO
-9.11%
73.26
TARS
-2.19%
23.27
PRVA
-2.39%

FAQ

What Is the Si-Bone (SIBN) Share Price Today?

The Si-Bone stock price today is 13.83 USD.

What Stock Exchange Does Si-Bone (SIBN) Trade On?

Si-Bone is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Si-Bone?

The stock symbol (also called a 'ticker') for Si-Bone is "SIBN."

What Is the Current Si-Bone Market Cap?

As of today, Si-Bone market cap is 610.81M USD.

What Is Si-Bone's (SIBN) Earnings Per Share (TTM)?

The Si-Bone EPS is currently -0.44 (Trailing Twelve Months).

When Is the Next Si-Bone Earnings Date?

Si-Bone's next earnings report will be released on 11/05/2026.

Is SIBN a Buy or Sell From a Technical Analyst Perspective?

Based on today's Si-Bone moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Si-Bone Stock Split?

Si-Bone has split 0 times. (See the SIBN stock split history page for full effective split date and price information.)

How Many Employees Does Si-Bone Have?

Si-Bone has 376 employees.

What is the current trading status of Si-Bone (SIBN)?

As of 07/03/2026, Si-Bone (SIBN) is trading at a price of 13.83 USD, with a previous close of 14.07 USD. The stock has fluctuated within a day range of 13.69 USD to 14.11 USD, while its 52-week range spans from 12.50 USD to 21.89 USD.

What Is Si-Bone (SIBN) Price Target According to Analysts?

The average 12-month price target for Si-Bone is 25.67 USD, with a high estimate of 32 USD and a low estimate of 22 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +85.59% Upside potential.

What Is the SIBN Premarket Price?

SIBN's last pre-market stock price is 14.00 USD. The pre-market share volume is 7.00, and the stock has decreased by -0.07, or -0.50%.

What Is the SIBN After Hours Price?

SIBN's last after hours stock price is 13.85 USD, the stock has decreased by 0.02, or 0.14%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.